• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

KDM3A 抑制通过抑制 MAPK/NF-κB 通路减轻高浓度胰岛素诱导的血管平滑肌细胞损伤。

KDM3A inhibition attenuates high concentration insulin‑induced vascular smooth muscle cell injury by suppressing MAPK/NF‑κB pathways.

机构信息

Department of Cardiology, Renmin Hospital of Wuhan University, Cardiovascular Research Institute, Wuhan University, Hubei Key Laboratory of Cardiology, Wuhan, Hubei 430060, P.R. China.

出版信息

Int J Mol Med. 2018 Mar;41(3):1265-1274. doi: 10.3892/ijmm.2017.3351. Epub 2017 Dec 29.

DOI:10.3892/ijmm.2017.3351
PMID:29286083
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5819917/
Abstract

Previous studies have indicated that lysine (K)‑specific demethylase 3A (KDM3A) is associated with diverse diabetes‑associated cardiovascular complications in response to high glucose levels. However, the effects of KDM3A on the pathological progression of cardiovascular injuries in response to high insulin levels remain unknown. The present study aimed to explore whether KDM3A knockdown may attenuate high insulin‑induced vascular smooth muscle cell (VSMC) dysfunction, and to further investigate the underlying mechanisms. Primary VSMCs were isolated from the thoracic aorta of Sprague‑Dawley rats. Lentiviral vectors encoding control‑small interfering (si)RNA or KDM3A‑siRNA were transduced into VSMCs for 72 h, and cells were subsequently incubated in medium containing 100 nM insulin for a further 5 days. Cellular proli-feration, migration and apoptosis were measured by Cell Counting kit‑8, Transwell chamber assay and flow cytometry, respectively. Reactive oxygen species (ROS) were detected using the dihydroethidium fluorescent probe. The mRNA expression levels of interleukin‑6 and monocyte chemotactic protein‑1 were measured by reverse transcription‑quantitative polymerase chain reaction. Furthermore, the protein expression levels of KDM3A, mitogen‑activated protein kinases (MAPKs), nuclear factor (NF)‑κB/p65, B‑cell lymphoma 2 (Bcl‑2)‑associated X protein and Bcl‑2 were evaluated by west-ern blotting. Lentivirus transduction with KDM3A‑siRNA markedly reduced the elevated expression of KDM3A induced by high insulin stimulation in VSMCs. In addition, inhibition of KDM3A significantly ameliorated insulin‑induced VSMC proliferation and migration, which was accompanied by decreased ROS levels, cell apoptosis and inflammatory cytokine levels. Furthermore, KDM3A gene silencing mitigated phosphorylation of MAPKs and NF‑κB/p65 activation. In conclusion, KDM3A inhibition may exert numerous protective effects on high insulin‑stimulated VSMCs, and the underlying mechanisms may be partly associated with inactivation of MAPK/NF‑κB signaling pathways.

摘要

先前的研究表明,赖氨酸特异性脱甲基酶 3A(KDM3A)与高糖水平下多种与糖尿病相关的心血管并发症有关。然而,KDM3A 对高胰岛素水平引起的心血管损伤病理进展的影响尚不清楚。本研究旨在探讨 KDM3A 敲低是否可以减轻高胰岛素诱导的血管平滑肌细胞(VSMC)功能障碍,并进一步探讨其潜在机制。从 Sprague-Dawley 大鼠的胸主动脉中分离原代 VSMC。将编码对照小干扰(si)RNA 或 KDM3A-siRNA 的慢病毒载体转染至 VSMC 中 72 h,随后将细胞在含有 100 nM 胰岛素的培养基中孵育 5 天。通过细胞计数试剂盒-8、Transwell 室测定和流式细胞术分别测量细胞增殖、迁移和凋亡。使用二氢乙啶荧光探针检测活性氧(ROS)。通过逆转录-定量聚合酶链反应测量白细胞介素-6 和单核细胞趋化蛋白-1 的 mRNA 表达水平。此外,通过 Western blot 评估 KDM3A、丝裂原活化蛋白激酶(MAPKs)、核因子(NF)-κB/p65、B 细胞淋巴瘤 2(Bcl-2)相关 X 蛋白和 Bcl-2 的蛋白表达水平。KDM3A-siRNA 的慢病毒转导显著降低了高胰岛素刺激诱导的 VSMC 中 KDM3A 的上调表达。此外,抑制 KDM3A 显著改善了胰岛素诱导的 VSMC 增殖和迁移,同时降低了 ROS 水平、细胞凋亡和炎症细胞因子水平。此外,KDM3A 基因沉默减轻了 MAPK/NF-κB 信号通路的激活。综上所述,KDM3A 抑制可能对高胰岛素刺激的 VSMC 发挥多种保护作用,其潜在机制可能部分与 MAPK/NF-κB 信号通路失活有关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3007/5819917/748ef9e2fa20/IJMM-41-03-1265-g04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3007/5819917/745326052203/IJMM-41-03-1265-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3007/5819917/a9d3e85658ae/IJMM-41-03-1265-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3007/5819917/01add46ed29f/IJMM-41-03-1265-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3007/5819917/d2f58f6c4e07/IJMM-41-03-1265-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3007/5819917/748ef9e2fa20/IJMM-41-03-1265-g04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3007/5819917/745326052203/IJMM-41-03-1265-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3007/5819917/a9d3e85658ae/IJMM-41-03-1265-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3007/5819917/01add46ed29f/IJMM-41-03-1265-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3007/5819917/d2f58f6c4e07/IJMM-41-03-1265-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3007/5819917/748ef9e2fa20/IJMM-41-03-1265-g04.jpg

相似文献

1
KDM3A inhibition attenuates high concentration insulin‑induced vascular smooth muscle cell injury by suppressing MAPK/NF‑κB pathways.KDM3A 抑制通过抑制 MAPK/NF-κB 通路减轻高浓度胰岛素诱导的血管平滑肌细胞损伤。
Int J Mol Med. 2018 Mar;41(3):1265-1274. doi: 10.3892/ijmm.2017.3351. Epub 2017 Dec 29.
2
Histone demethylase KDM3a, a novel regulator of vascular smooth muscle cells, controls vascular neointimal hyperplasia in diabetic rats.组蛋白去甲基化酶 KDM3a,一种血管平滑肌细胞的新型调节因子,可控制糖尿病大鼠的血管新生内膜增生。
Atherosclerosis. 2017 Feb;257:152-163. doi: 10.1016/j.atherosclerosis.2016.12.007. Epub 2016 Dec 9.
3
Salusin-β Promotes Vascular Smooth Muscle Cell Migration and Intimal Hyperplasia After Vascular Injury via ROS/NFκB/MMP-9 Pathway.沙利素-β通过 ROS/NFκB/MMP-9 通路促进血管损伤后血管平滑肌细胞迁移和内膜增生。
Antioxid Redox Signal. 2016 Jun 20;24(18):1045-57. doi: 10.1089/ars.2015.6475. Epub 2016 Apr 8.
4
Artemisinin inhibits the proliferation, migration, and inflammatory reaction induced by tumor necrosis factor-α in vascular smooth muscle cells through nuclear factor kappa B pathway.青蒿素通过核因子κB途径抑制肿瘤坏死因子-α诱导的血管平滑肌细胞增殖、迁移及炎症反应。
J Surg Res. 2015 Apr;194(2):667-678. doi: 10.1016/j.jss.2014.12.013. Epub 2014 Dec 11.
5
Regulation of angiotensin II-induced B-cell lymphoma-2-associated athanogene 3 expression in vascular smooth muscle cells.血管平滑肌细胞中血管紧张素 II 诱导的 B 细胞淋巴瘤-2 相关抗凋亡基因 3 表达的调节。
Mol Med Rep. 2018 Apr;17(4):6156-6162. doi: 10.3892/mmr.2018.8630. Epub 2018 Feb 22.
6
Inhibition of neointimal hyperplasia in the rat carotid artery injury model by a HMGB1 inhibitor.HMGB1 抑制剂抑制大鼠颈动脉损伤模型中的新生内膜增生。
Atherosclerosis. 2012 Oct;224(2):332-9. doi: 10.1016/j.atherosclerosis.2012.07.020. Epub 2012 Jul 24.
7
17beta-estradiol down-regulates lipopolysaccharide-induced MCP-1 production and cell migration in vascular smooth muscle cells.17β-雌二醇下调脂多糖诱导的血管平滑肌细胞中单核细胞趋化蛋白-1 的产生和细胞迁移。
J Mol Endocrinol. 2010 Aug;45(2):87-97. doi: 10.1677/JME-09-0166. Epub 2010 Jun 10.
8
Adipose differentiation‑related protein knockdown inhibits vascular smooth muscle cell proliferation and migration and attenuates neointima formation.脂肪分化相关蛋白敲低抑制血管平滑肌细胞增殖和迁移并减轻新生内膜形成。
Mol Med Rep. 2017 Sep;16(3):3079-3086. doi: 10.3892/mmr.2017.6997. Epub 2017 Jul 15.
9
Grape seed proanthocyanidins attenuate vascular smooth muscle cell proliferation via blocking phosphatidylinositol 3-kinase-dependent signaling pathways.葡萄籽原花青素通过阻断磷脂酰肌醇 3-激酶依赖性信号通路来减轻血管平滑肌细胞增殖。
J Cell Physiol. 2010 Jun;223(3):713-26. doi: 10.1002/jcp.22080.
10
Tanshinone IIA inhibits lipopolysaccharide‑induced inflammatory responses through the TLR4/TAK1/NF‑κB signaling pathway in vascular smooth muscle cells.丹参酮 IIA 通过 TLR4/TAK1/NF-κB 信号通路抑制血管平滑肌细胞中的脂多糖诱导的炎症反应。
Int J Mol Med. 2019 Apr;43(4):1847-1858. doi: 10.3892/ijmm.2019.4100. Epub 2019 Feb 18.

引用本文的文献

1
KDM3A Modulates Trastuzumab Resistance in HER2- Positive Breast Cancer Cells via the PI3K/AKT/ERK Pathway.KDM3A通过PI3K/AKT/ERK途径调节HER2阳性乳腺癌细胞中的曲妥珠单抗耐药性。
Biochem Genet. 2025 Jul 2. doi: 10.1007/s10528-025-11170-8.
2
Histone demethylases in autophagy and inflammation.自噬与炎症中的组蛋白去甲基化酶
Cell Commun Signal. 2025 Jan 13;23(1):24. doi: 10.1186/s12964-024-02006-w.
3
Protective effects of Shexiang-Tongxin dropping pill against acute myocardial infarction in rats through inhibition of apoptosis and ERK/MAPK signaling pathways.

本文引用的文献

1
The Contribution of Diabetes Education in the Treatment of People with Type 2 Diabetes and Risk of Cardiovascular Disease.
Curr Atheroscler Rep. 2016 Jul;18(7):44. doi: 10.1007/s11883-016-0591-4.
2
Novel Biomarkers to Improve the Prediction of Cardiovascular Event Risk in Type 2 Diabetes Mellitus.改善2型糖尿病心血管事件风险预测的新型生物标志物
J Am Heart Assoc. 2016 May 31;5(6):e003048. doi: 10.1161/JAHA.115.003048.
3
Prognostic value of gamma-glutamyl transferase in patients with diabetes mellitus and coronary artery disease.γ-谷氨酰转移酶在糖尿病合并冠状动脉疾病患者中的预后价值
麝香通心滴丸通过抑制细胞凋亡和ERK/MAPK信号通路对大鼠急性心肌梗死的保护作用。
Heliyon. 2024 Oct 29;10(21):e39939. doi: 10.1016/j.heliyon.2024.e39939. eCollection 2024 Nov 15.
4
Silencing of Jumonji domain-containing 1C inhibits the osteogenic differentiation of bone marrow mesenchymal stem cells nuclear factor-κB signaling.含Jumonji结构域蛋白1C的沉默通过抑制核因子-κB信号传导抑制骨髓间充质干细胞的成骨分化
World J Stem Cells. 2024 Feb 26;16(2):151-162. doi: 10.4252/wjsc.v16.i2.151.
5
MicroRNA-214-3p protects against myocardial ischemia-reperfusion injury by targeting demethylase lysine demethylase 3A.微小RNA-214-3p通过靶向去甲基化酶赖氨酸去甲基化酶3A来保护心肌缺血再灌注损伤。
Regen Ther. 2023 Mar 24;23:17-24. doi: 10.1016/j.reth.2023.01.008. eCollection 2023 Jun.
6
The Role of PKC-MAPK Signalling Pathways in the Development of Hyperglycemia-Induced Cardiovascular Complications.蛋白激酶 C-丝裂原活化蛋白激酶信号通路在高血糖诱导心血管并发症发生发展中的作用。
Int J Mol Sci. 2022 Aug 2;23(15):8582. doi: 10.3390/ijms23158582.
7
Expression of proliferation-related genes in BM-MSC-treated ALL cells in hypoxia condition is regulated under the influence of epigenetic factors in-vitro.在体外条件下,缺氧环境中 BM-MSC 治疗 ALL 细胞中与增殖相关的基因的表达受表观遗传因素的影响。
Med Oncol. 2022 May 18;39(5):88. doi: 10.1007/s12032-022-01671-6.
8
KDM3A Inhibition Ameliorates Hyperglycemia-Mediated Myocardial Injury by Epigenetic Modulation of Nuclear Factor Kappa-B/P65.KDM3A抑制通过对核因子κB/P65的表观遗传调控改善高血糖介导的心肌损伤。
Front Cardiovasc Med. 2022 Apr 29;9:870999. doi: 10.3389/fcvm.2022.870999. eCollection 2022.
9
The histone demthylase KDM3A protects the myocardium from ischemia/reperfusion injury via promotion of ETS1 expression.组蛋白去甲基化酶 KDM3A 通过促进 ETS1 表达来保护心肌免受缺血/再灌注损伤。
Commun Biol. 2022 Mar 25;5(1):270. doi: 10.1038/s42003-022-03225-y.
10
Histone Methylation Related Therapeutic Challenge in Cardiovascular Diseases.心血管疾病中组蛋白甲基化相关的治疗挑战
Front Cardiovasc Med. 2021 Sep 9;8:710053. doi: 10.3389/fcvm.2021.710053. eCollection 2021.
Clin Biochem. 2016 Oct;49(15):1127-1132. doi: 10.1016/j.clinbiochem.2016.05.018. Epub 2016 May 21.
4
Salusin-β Promotes Vascular Smooth Muscle Cell Migration and Intimal Hyperplasia After Vascular Injury via ROS/NFκB/MMP-9 Pathway.沙利素-β通过 ROS/NFκB/MMP-9 通路促进血管损伤后血管平滑肌细胞迁移和内膜增生。
Antioxid Redox Signal. 2016 Jun 20;24(18):1045-57. doi: 10.1089/ars.2015.6475. Epub 2016 Apr 8.
5
Coordinated augmentation of NFAT and NOD signaling mediates proliferative VSMC phenotype switch under hyperinsulinemia.在高胰岛素血症情况下,NFAT和NOD信号的协同增强介导增殖性血管平滑肌细胞表型转换。
Atherosclerosis. 2016 Mar;246:257-66. doi: 10.1016/j.atherosclerosis.2016.01.006. Epub 2016 Jan 13.
6
Isovitexin Exerts Anti-Inflammatory and Anti-Oxidant Activities on Lipopolysaccharide-Induced Acute Lung Injury by Inhibiting MAPK and NF-κB and Activating HO-1/Nrf2 Pathways.异荭草素通过抑制MAPK和NF-κB以及激活HO-1/Nrf2信号通路对脂多糖诱导的急性肺损伤发挥抗炎和抗氧化活性。
Int J Biol Sci. 2016 Jan 1;12(1):72-86. doi: 10.7150/ijbs.13188. eCollection 2016.
7
Effect of glycemic state on postprandial hyperlipidemia and hyperinsulinemia in patients with coronary artery disease.血糖状态对冠心病患者餐后高脂血症和高胰岛素血症的影响。
Heart Vessels. 2016 Sep;31(9):1446-55. doi: 10.1007/s00380-015-0757-y. Epub 2015 Oct 6.
8
Histone Demethylase JMJD2A Inhibition Attenuates Neointimal Hyperplasia in the Carotid Arteries of Balloon-Injured Diabetic Rats via Transcriptional Silencing: Inflammatory Gene Expression in Vascular Smooth Muscle Cells.组蛋白去甲基化酶JMJD2A抑制通过转录沉默减轻球囊损伤糖尿病大鼠颈动脉的内膜增生:血管平滑肌细胞中的炎症基因表达
Cell Physiol Biochem. 2015;37(2):719-34. doi: 10.1159/000430390. Epub 2015 Sep 11.
9
Isoliensinine induces apoptosis in triple-negative human breast cancer cells through ROS generation and p38 MAPK/JNK activation.异莲心碱通过产生活性氧和激活p38丝裂原活化蛋白激酶/应激活化蛋白激酶诱导三阴性人乳腺癌细胞凋亡。
Sci Rep. 2015 Jul 29;5:12579. doi: 10.1038/srep12579.
10
MiR-135b-5p and MiR-499a-3p Promote Cell Proliferation and Migration in Atherosclerosis by Directly Targeting MEF2C.MiR-135b-5p和MiR-499a-3p通过直接靶向MEF2C促进动脉粥样硬化中的细胞增殖和迁移。
Sci Rep. 2015 Jul 17;5:12276. doi: 10.1038/srep12276.